Home » Healthcare » Pharmaceuticals » Opioid Drugs Market

Opioid Drugs Market By Drug Type (Opioid Agonist (Morphine, Methadone, Codeine, Oxycodone, Meperidine, Fentanyl and Other Agonist), Opioid Antagonist (Naloxone, Naltrexone and Other Antagonist), By Application Type (Pain Management, Cough Suppressant, Diarrhea and Anesthesia)) – Growth, Future Prospects and Competitive Analysis, 2017 – 2025

Name: Opioid Drugs Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2017-11-30
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Opioid Drugs Market

Summary
Table Of Content
Request Sample

Market Insights:

Opioids are a drug class including a broad range of drugs such as morphine, oxycodone, fentanyl, hydrocodone, and others with widened applications in pain management. Opioid drugs produce effective results by interacting with opioid receptors present in nerve cells. Globally, millions of people have been suffering from acute or chronic pain, thus having a huge impact on domestic healthcare expenditure and supporting the growth opportunity of the opioid drug market. Significant risk is associated with the misuse of opioid drugs; therefore, it is recommended that these drugs be taken in the proper dose and under the appropriate conditions, with a physician’s prescription.

Global sales of opioid drugs are greatly influenced by epidemiological factors such as the high prevalence of cancer and chronic disorders. The growing elderly population, who are at high risk of suffering from mild to moderate pain, is also driving the opioid drug market. Trends toward purchasing over-the-counter opioid drugs and surging demand for recreational drugs are predicted to boost the growth of the opioid drug market. Deaths caused by opioid overdose have been escalating in recent years, which is an epidemic in the United States. As per the record of the Centers for Disease Control and Prevention (CDC), opioids caused the deaths of more than 33,000 people in 2015, and more than half of them were due to prescribed opioids.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

The rapidly rising trend of opioid overdose and addiction has emerged as a global health concern, and many initiatives have been launched by governments and healthcare organizations to halt the growth of the opioid drug market. Market penetration of non-opioid drugs to avoid side effects and risks associated with opioid drugs also limits the opioid drug market’s growth opportunity.

The global opioid drugs market has been segmented on the basis of drug type and application type. Opioid drugs are classified into morphine, methadone, codeine, oxycodone, meperidine, fentanyl, and others, whereas, as per application, the market is categorized into pain management, cough suppression, anesthesia, and diarrhea. This report is comprised of the cross-sectional details of every segment and sub-segment, containing data for the base year of 2016 and projected to 2025 with a corresponding CAGR calculated from 2017 to 2025.

The report on the global opioid drugs market offers detailed market insights and a comprehensive analysis of market dynamics, comprising market drivers, restraints, and opportunities, with future prospects for the opioid drugs market to allow industry experts to identify business opportunities and valuable information about the prevailing trend of the market to make business decisions. A competitive landscape analysis of manufacturers with mergers and acquisitions activities, major partnerships, and collaboration has been delivered in the study to develop accurate business strategies.

Actavis Plc., Boehringer Ingelheim, Endo Pharmaceuticals Inc., Egalet, Janssen Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals Inc., Pfizer Inc., Purdue Pharma, Sanofi, and Sun Pharmaceutical Industries Ltd. is a few of the major manufacturers of the global opioid drugs market. This research report includes detailed profiles of these players, as well as a brief description and financial data.

Based on the wide application range of opioid drugs, this market is categorized as follows:

Pain Management
Cough Suppressant
Diarrhea
Anesthesia

Pain management is estimated to be the spearheading segment as a result of the effective outcomes of opioid drugs. Opioid drugs play an important role in treating acute or chronic pain. The World Health Organization stated that 80% of cancer or AIDS patients and around 67% of patients suffering from pulmonary disease and cardiovascular diseases need medical intervention to relieve pain, and this high trend drives the opioid drug market. The opioid codeine is used as the “gold standard” for cough suppression. However, the FDA’s strict regulation of opioid drug use in pediatric patients has a negative impact on the global opioid drug market. Opioid drugs are effective for treating chronic diarrhea by lengthening the time it takes to pass stool from the gut; furthermore, the severe side effects of opioid drugs on inducing constipation might hinder the demand for opioid drugs. Opioid drugs are largely used as an anesthetic agent, especially in cardiovascular surgical procedures, and with the increasing number of surgical interventions, the market for opioid drugs is expected to witness major growth.

Based on the drug types, the global market for opioid drugs has been classified as follows:

Morphine
Methadone
Codeine
Oxycodone
Meperidine
Fentanyl
Other opioid drugs

Morphine and codeine are the most commonly used opioid drugs, and they contribute significantly to the global opioid drugs market. Morphine is widely used in the treatment of moderate to severe pain. The rising prevalence of cancer, arthritis, and chronic pain, and increased recreational use of morphine are driving the global market for opioid drugs; however, the drug’s side effects and risks may have an impact on the market’s growth. Surging demand for codeine in pain relief and cough suppression fuels the growth of the opioid drugs market; however, strict action against illegal, over-the-counter codeine drug use is expected to have an impact on the global opioid drugs market in the coming years. Methadone is gaining popularity due to its effective treatment of opioid addiction by reducing withdrawal symptoms and diminishing cravings, thus supporting market growth. Fentanyl is more potent in the treatment of severe pain; the demand for this drug in the treatment of surgical pain, as well as its increasing addiction, has driven global opioid drug sales.

Geographically, the global opioid drugs market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.North America is predicted to experience the largest growth due to the continuous increase in demand for opioid drugs, followed by Europe. The National Institutes of Health has reported that in 2015, around 50 million Americans were suffering from severe chronic pain. Such a high prevalence of acute and chronic pain acts as the major driver of the opioid drug market in North America. According to the American Society of Interventional Pain Physicians (ASIPP), 80% of global opioid drugs are being consumed in the United States; such a high consumption rate and the overall increment in retail sales over the last two decades have driven the opioid drug market in this region.

In terms of commercial growth, increasing illicit use of opioid drugs such as heroin fuels the opioid drug market. According to data from the Centers for Disease Control and Prevention (CDC), opioid overdose killed approximately 28,000 people in the United States in 2014. To fight against this epidemic, several initiatives have been taken by the government to prevent opioid overdose and dependence, which are expected to affect the overall growth of the opioid drug market. Europe is expected to experience steady growth as a result of lower non-medical usage of opioids than the United States and strict vigilance against opioid abuse.

Furthermore, rapid development in healthcare expenditure and attention to palliative care for therapy are expected to promote the growth of the opioid drug market in the Asia Pacific. The boom in the market for opioids in China is due to the increasing rate of cancer cases and rising surgical interventions.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

The report contains detailed geographical segmentation as below:

North America (the United States and Canada)
Europe (Britain, Germany, and the Rest of Europe)
Asia Pacific (China, Japan, India, & the Rest of APAC)
Latin America (Brazil, Mexico, and the Rest of Latin America)
Middle East and Africa (GCC and the rest of the Middle East and Africa)

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Opioid Drugs Market Portraiture
2.1.1. Global Opioid Drugs Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Opioid Drugs Market, by Application, 2016 (US$ Mn)
2.1.3. Global Opioid Drugs Market, by Geography, 2016 Vs. 2025 (Value %)

Chapter 3. Opioid Drugs Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Opioid Drugs: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Opioid Drugs Market, by Drug Type, 2016
4.2. Morphine
4.3. Methadone
4.4. Codeine
4.5. Oxycodone
4.6. Meperidine
4.7. Fentanyl
4.8. Others

Chapter 5. Global Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Opioid Drugs Market, by Application, 2016
5.2. Pain Management
5.3. Cough Suppressant
5.4. Diarrhea
5.5. Anesthesia

Chapter 6. Global Erectile Dysfunction Treatment Drugs Market: Pipeline Analysis
6.1. Overview
6.2. Phase III (Market estimations by 2025)
6.2.1. NKTR 181 (Nektar Therapeutics)
6.3. Phase II (Qualitative Information)
6.4. Phase I (Qualitative Information)
6.5. Preclinical Studies (Quantitative Information)

Chapter 7. Global Opioid Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Opioid Drugs Market Analysis, 2015 – 2025
7.2.1. North America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.2.3. North America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.2.3.1. U.S.
7.2.3.2. Canada
7.3. Europe Opioid Drugs Market Analysis, 2015 – 2025
7.3.1. Europe Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.3.3. Europe Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.3.3.1. U.K.
7.3.3.2. Germany
7.3.3.3. Rest of Europe
7.4. Asia Pacific Opioid Drugs Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.4.3.1. Japan
7.4.3.2. China
7.4.3.3. India
7.4.3.4. Rest of APAC
7.5. Latin America Opioid Drugs Market Analysis, 2015 – 2025
7.5.1. Latin America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.5.3.1. Brazil
7.5.3.2. Mexico
7.5.3.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Opioid Drugs Market Analysis, 2015 – 2025
7.6.1. MEA Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
7.6.3. MEA Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
7.6.3.1. GCC
7.6.3.2. South Africa
7.6.3.3. Rest of MEA

Chapter 8. Company Profiles
8.1. Actavis Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Boehringer Ingelheim
8.3. Endo Pharmaceuticals Inc.
8.4. Egalet
8.5. Janssen Pharmaceuticals, Inc.
8.6. Mallinckrodt Pharmaceuticals
8.7. Pfizer Inc.
8.8. Purdue Pharma
8.9. Sanofi
8.10. Sun Pharmaceutical Industries Ltd.

List of Figures

FIG. 1 Opioid Drugs: Market Segmentation
FIG. 2 Global Opioid Drugs Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Opioid Drugs Market Share, by Application, 2016 (US$ Mn)
FIG. 4 Global Opioid Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2016
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Morphine Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Methadone Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Codeine Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Oxycodone Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Meperidine Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Fentanyl Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Other Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Opioid Drugs Market for Pain Management, 2015 – 2025 (US$ Mn)
FIG. 15 Global Opioid Drugs Market for Cough Suppressant, 2015 – 2025 (US$ Mn)
FIG. 16 Global Opioid Drugs Market for Diarrhea, 2015 – 2025 (US$ Mn)
FIG. 17 Global Opioid Drugs Market for Anesthesia, 2015 – 2025 (US$ Mn)
FIG. 18 U.S. Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 19 Canada Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 20 U.K. Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 21 Germany Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Europe Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 23 Japan Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 24 China Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 25 India Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest Of Asia Pacific Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 27 Brazil Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 28 Mexico Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 29 Rest Of Latin America Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 30 GCC Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 31 South Africa Opioid Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 32 Rest Of Middle East And Africa Opioid Drugs Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Opioid Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 North America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn
TABLE 13 Latin America Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn
TABLE 16 Middle East and Africa Opioid Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Opioid Drugs Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Opioid Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Actavis Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Endo Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Egalet: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Janssen Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Purdue Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Sanofi: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Sun Pharmaceutical Industries Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions:

What is the size of Opioid Drugs Market?

The market for Opioid Drugs Market is expected to reach US$ XX Mn by 2025.

What is the Opioid Drugs Market CAGR?

The Opioid Drugs Market is expected to see significant CAGR growth over the coming years, at 4.4%.

What is the Forecast period considered for Opioid Drugs Market?

The report is forecasted from 2017-2025.

What is the base year considered for Opioid Drugs Market?

The base year of this report is 2016.

Who are the major players in this market?

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Point of Care Opioid Testing Market

The Point of Care Opioid Testing Market is projected to grow from USD 475.9 million in 2024 to USD 719.35 million by 2032, with a compound annual growth rate (CAGR) of 5.3%.

Opioid Use Disorder Treatment Market

The Opioid Use Disorder Treatment Market is projected to grow from USD 3085 million in 2024 to an estimated USD 7109.49 million by 2032, with a compound annual growth rate (CAGR) of 11% from 2024 to 2032.

Non-Opioid Pain Patch Market

The global Non-Opioid Pain Patch Market is projected to grow from USD 3,602.81 million in 2023 to an estimated USD 5,239.94 million by 2032, registering a compound annual growth rate (CAGR) of 4.25% from 2024 to 2032.

Opioid Induced Constipation (OIC) Drugs Market

The Opioid Induced Constipation (OIC) Drugs Market is projected to grow from USD 2,089.5 million in 2023 to an estimated USD 2,926.28 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.30% from 2024 to 2032.

Non Opioid Pain Treatment Market

The Non Opioid Pain Treatment Market is projected to grow from USD 78883 million in 2024 to an estimated USD 150389.55 million by 2032, with a compound annual growth rate (CAGR) of 8.4% from 2024 to 2032.

Veterinary Pain Management Market

The Veterinary Pain Management Market size was valued at USD 2,030.00 million in 2018 to USD 2,433.71 million in 2024 and is anticipated to reach USD 4,010.35 million by 2032, at a CAGR of 6.51% during the forecast period.

Malaysia Chronic Pain Market

The Chronic Pain Market In Malaysia is expected to grow from USD 143.77 million in 2024 to USD 218.48 million by 2032, with a compound annual growth rate (CAGR) of 5.37%.

Radiofrequency Ablation Devices for Pain Management Market

The Radiofrequency Ablation Devices For Pain Management Market is projected to grow from USD 1,584 million in 2024 to USD 3,042.24 million by 2032, expanding at a CAGR of 8.5% during the forecast period.

Chronic Refractory Cough Treatment Market

The Chronic Refractory Cough Treatment Market is projected to grow from USD 1,625 million in 2024 to USD 3,007.76 million by 2032, reflecting a compound annual growth rate (CAGR) of 8% during the forecast period 2024-2032.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample